The global digital health market is poised for robust growth over the next decade, with its value projected to rise from USD 347.4 billion in 2025 to USD 1,830.4 billion by 2033, reflecting a compound annual growth rate (CAGR) of 23.4% between 2026 and 2033, according to a recent report by Grand View Research.

The rapid evolution of healthcare delivery, widespread adoption of digital technologies in clinical settings, increasing demand for remote healthcare solutions, and the growing emphasis on patient-centered care are driving the expansion of the global digital health market. Governments, healthcare providers, and technology companies worldwide are investing heavily in digital infrastructure to enhance healthcare accessibility, efficiency, and patient outcomes.

Digital Technologies Transforming Healthcare Systems
Digital health solutions have become an essential component of modern healthcare by enabling connected care, virtual consultations, electronic health records, real-time patient monitoring, and data-driven clinical decision-making. Factors such as the rising burden of chronic diseases, shortages of healthcare professionals, increasing healthcare expenditures, and growing consumer preference for convenient healthcare services continue to support market growth.

The widespread use of smartphones, improved internet access, advances in healthcare IT systems, and rising investments in health technologies are accelerating the global adoption of digital health platforms. Solutions such as remote patient monitoring, telehealth services, and mobile health applications are increasingly being utilized to provide continuous access to healthcare services.

Telehealth and Mobile Health Continue to Drive Expansion
Among technology segments, telehealth accounted for the largest share of the digital health market in 2025, representing 44.7% of total revenue. This growth has been fueled by rising demand for virtual healthcare services, expanding internet connectivity, increasing smartphone usage, and greater acceptance of remote consultations.

Advancements in telehealth platforms have enabled healthcare professionals to provide consultations, patient monitoring, and follow-up care outside traditional clinical environments. Growing healthcare costs and the need to improve access in underserved regions are further accelerating the adoption of virtual care models.

At the same time, the mobile health (mHealth) segment is experiencing rapid growth as consumers increasingly rely on smartphones and wearable devices to monitor health conditions, manage chronic illnesses, and access personalized healthcare services. Continued improvements in mobile technologies and digital awareness are expected to further support this segment's expansion.

Software Solutions Account for the Largest Market Share
Based on component type, software represented the largest share of the digital health market in 2025, accounting for 45.7% of revenue. The segment's growth is being driven by the increasing adoption of healthcare software platforms by patients, providers, insurers, and medical institutions.

Healthcare organizations are deploying a broad range of digital solutions, including electronic health record (EHR) systems, healthcare analytics platforms, digital therapeutics, and clinical management software to enhance operational performance and improve patient care.

The integration of artificial intelligence (AI), machine learning, and advanced analytics technologies is also reshaping healthcare by supporting predictive analytics, more accurate diagnoses, and personalized treatment strategies.

Growing Chronic Disease Burden Supports Market Demand
The increasing prevalence of chronic conditions such as diabetes, cardiovascular disease, and cancer is creating substantial demand for digital healthcare technologies that enable continuous monitoring and disease management.

The diabetes application segment accounted for more than 25% of the market in 2025, driven by increasing adoption of glucose monitoring systems, digital disease management platforms, wearable technologies, and remote patient monitoring solutions.

Digital health platforms are empowering patients by improving access to healthcare information, supporting medication adherence, and enabling healthcare providers to remotely monitor patient health and treatment outcomes.

Patient-Centered Care Models Create New Opportunities
Patients represented the largest end-user segment in 2025, accounting for more than 35% of total market revenue, and are expected to maintain strong growth throughout the forecast period. The rising focus on personalized care, self-management tools, and improved patient engagement continues to drive adoption.

Digital healthcare solutions, including mobile applications, wearable devices, telehealth platforms, and connected medical technologies, are enabling patients to take a more active role in preventive care and disease management.

Healthcare providers are likewise adopting digital tools to improve clinical workflows, increase operational efficiency, and deliver more personalized treatment approaches.

North America Leads While Asia Pacific Emerges as a High-Growth Region
North America held the largest share of the global digital health market in 2025, accounting for 37.1% of total revenue. The region's leadership is supported by advanced healthcare infrastructure, significant healthcare IT investments, supportive government policies, and rapid adoption of emerging technologies.

The region continues to attract substantial investment from healthcare organizations, technology companies, and startups focused on developing innovative digital health solutions.
Meanwhile, the Asia Pacific market is expected to experience strong growth during the forecast period, driven by increasing smartphone penetration, improving healthcare infrastructure, expanding digital literacy, and government initiatives aimed at accelerating healthcare digitalization.

Investments and Innovation Intensify Industry Competition
The digital health sector is witnessing growing levels of investment, strategic partnerships, and technological innovation as companies seek to strengthen and expand their digital healthcare capabilities. Industry participants are actively developing solutions across telehealth, healthcare analytics, wearable devices, remote monitoring, and connected healthcare ecosystems.

Major companies operating in the market include Oracle Cerner, Veradigm, Apple Inc., Telefonica S.A., McKesson Corporation, Epic Systems Corporation, Google, Samsung Electronics, IBM Corporation, and Cisco Systems.

Recent developments across the industry underscore a growing focus on artificial intelligence integration, digital care delivery models, and technology-enabled healthcare services. These innovations are expected to unlock new opportunities for market participants while improving healthcare access on a global scale.

Digital Health Market Outlook
The global digital health industry is entering a period of accelerated transformation as healthcare systems increasingly embrace technology-driven solutions to improve patient outcomes and operational performance. The convergence of advanced connectivity, AI-powered healthcare applications, rising healthcare investments, and growing demand for remote care services is expected to drive sustained market expansion through 2033.

According to Grand View Research, the digital health market is on track to reach USD 1,830.4 billion by 2033, highlighting the continued shift toward more connected, accessible, and personalized healthcare ecosystems worldwide.

Since its inception in 1887, BMS has been instrumental in positively impacting patients globally, and I am privileged to carry forward this rich legacy as Board Chair and CEO. Upholding this legacy is a significant responsibility that demands our unwavering commitment to the values and principles that have been the bedrock of our past achievements, while charting the course for BMS' future.
 
In an increasingly intricate global landscape, our unified strategy, encompassing our ESG performance, holds greater significance than ever before. This is why, in 2023, we actively engaged with a spectrum of stakeholders, including patient advocacy groups, shareholders, suppliers, employees, international organizations, and our Board, to discern their perspectives on ESG matters pertinent to our business and society. Drawing from these insights, we refined our ESG strategy with a primary focus on advancing global patient health, nurturing a diverse and high-performing workforce, and pushing the boundaries of scientific exploration, all while endeavoring to mitigate our environmental footprint.
 
Advancing global patient health remains paramount in our mission. Irrespective of geographical location, patients continue to face barriers to accessing essential medicines and healthcare services. We are steadfast in our commitment to implementing sustainable solutions to address these health disparities worldwide. This involves dedicating specific resources and pioneering new approaches to expand access, particularly in low- and middle-income countries (LMICs).
 
To realize this vision, we are integrating accessibility considerations into the fabric of our operations, instigating a transformative shift in our approach. From raising awareness about the societal impact of medical conditions to advocating for broader public reimbursement for our innovative medicines, our efforts encompass a spectrum of initiatives aimed at alleviating the burden on patients.

In LMICs, tailored programs are being developed to enhance access to our innovative portfolio, resulting in significant strides. We have facilitated access to 12 transformative products across 80+ LMICs, with over 40 of these products being provided to low-income countries at not-for-profit or adjusted pricing. Furthermore, our global policy collaborations are geared towards fortifying healthcare systems, thus ensuring sustainable benefits for patients and communities.
 
In tandem with our commitment to patient welfare, we are unwavering in our dedication to scientific advancement. By fostering a culture of excellence and investing in R&D capabilities, we strive to expedite the development and delivery of life-changing medicines. With one of the most diverse portfolios and pipelines in the pharmaceutical industry, we are uniquely positioned to drive innovation across therapeutic areas. Leveraging our differentiated research platforms, including cell therapy and targeted protein degradation, we aim to broaden treatment options and alleviate the burden of diseases worldwide.
 
The recent approvals of our medicines and those in our imminent pipeline signify the culmination of effective execution and collaboration throughout our organization. Over the past three years, we've garnered over 50 global regulatory approvals, showcasing our dedication to advancing patient care.
 
As part of our pledge, we recognize the significance of enrolling clinical trial populations that mirror real-world demographics and align with the epidemiology of the diseases under study. By doing so, we aim to overcome barriers to achieving health equity and enhance our understanding of the safety and efficacy of groundbreaking medicines across diverse populations. We acknowledge the need to extend these efforts to comprehend the implications of diversity in clinical trials across various countries and patient characteristics.
 
Nurturing a globally inclusive and high-performing workforce is a cornerstone of our ethos at BMS, rooted in our core values of Integrity, Innovation, Passion, Inclusion, Accountability, and Urgency. By embodying these values, we empower our employees to excel, ensuring we meet the needs of our patients.
 
An inclusive and diverse workplace fosters innovation and ensures that diverse perspectives are valued and integrated into our mission of transforming patients' lives through science. This necessitates the incorporation of inclusive practices across all facets of our organization, including talent management, leadership development, and learning initiatives.
 
Prioritizing the health and wellbeing of our workforce remains paramount. We continually assess and enhance our programs to support the physical, emotional, professional, and financial wellbeing of our employees, enabling them to thrive in their roles.
 
Recognizing our environmental responsibility, we are committed to minimizing our operational impact on the planet. Our environmental goals, including achieving Net-Zero emissions in Scopes 1, 2, and 3 by 2050, underscore our commitment to sustainability and accountability through robust governance and transparent reporting.
 
Corporate responsibility has long been integral to BMS, and our evolved ESG strategy reflects our organization-wide dedication to advancing sustainability. Together, we are forging a legacy that blends our esteemed history with a future characterized by innovation, responsibility, and growth.